<DOC>
	<DOCNO>NCT02873468</DOCNO>
	<brief_summary>The purpose study evaluate efficacy three dose fluticasone propionate oral ( viscous suspension ) change eosinophilic infiltration esophageal biopsy .</brief_summary>
	<brief_title>Safety Efficacy Three Doses Oral Fluticasone Propionate Adults With Eosinophilic Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Signed Consent patient ; Participants present eosinophilic esophagitis confirm endoscopy 15 eosinophils/hpf clinical symptom ; Patients clinically significant disease investigator opinion can´t participate study ; Patients laboratory find image find investigator opinion can´t participate clinical trial ; Patients history hypersensitivity formula compound ; Participation clinical trial year prior study ; Pregnancy risk pregnancy lactate patient ; Patients diseases esophagus / erosive esophagitis ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>